The traditional computer interface, characterized by keyboards and screens, may soon be a relic of the past, according to Max Hodak, CEO of Science Corporation. Hodak is pioneering a new era of human-machine interaction, focusing on biohybrid brain-computer interfaces (BCIs) that adapt to users. His company is actively advancing this vision, having enlisted a leading neurobiologist to spearhead the first U.S. human trials for its groundbreaking technology.

Speaking at TechCrunch Disrupt 2026, Hodak is set to articulate his perspective on how brain-computer interactions could redefine our engagement with technology. This shift promises to move beyond the limitations of current screen-based systems, offering novel ways for humans to interact with machines. The event itself, held at Moscone West in San Francisco from October 13-15, will convene over 10,000 tech leaders, founders, and investors, with a significant emphasis on the development of sustainable AI companies.

Hodak’s career trajectory reflects a consistent belief in the potential for significant improvements in human-computer interfaces. With a background in biomedical engineering and early experience in brain-computer interface research, he co-founded Neuralink, a company that brought brain implants into mainstream discussion. Subsequently, he founded Science Corporation in 2021, dedicated to developing advanced neural engineering and BCI technologies. The company’s mission includes creating applications to assist individuals with challenges in vision, cognition, and mobility.

Science Corp’s innovative PRIMA implant has already demonstrated success in restoring sight for individuals with severe vision impairment. This device works in conjunction with specialized glasses that capture visual information and transmit it to a retinal implant. The company has secured substantial funding, raising $230 million in a Series C round, valuing it at $1.5 billion. Beyond visual restoration, Science Corp is exploring the use of its brain-implanted sensors for therapeutic purposes, including healing damaged brain cells, predicting seizures, and potentially treating neurodegenerative conditions like Parkinson’s disease.

Key Takeaways

• Science Corp CEO Max Hodak believes the era of screen-based computing is ending, advocating for brain-computer interfaces as the future.
• The company's PRIMA implant has successfully restored vision in individuals with severe impairment, utilizing a camera-equipped glasses and retinal implant system.
• Science Corp is exploring broader applications for its BCI technology, including therapeutic uses for neurological conditions and cognitive enhancement.

Editor’s Analysis & Impact

Max Hodak’s vision for a post-screen future, driven by advanced brain-computer interfaces, represents a significant potential paradigm shift in human-technology interaction. The success of Science Corp’s PRIMA implant in restoring vision underscores the tangible progress being made in neural engineering. If the company can replicate this success in therapeutic applications for conditions like Parkinson’s or cognitive decline, it could revolutionize healthcare and redefine human capabilities. This development positions BCIs not just as a novel interface, but as a powerful tool for medical intervention and enhancement, with profound implications for the tech and healthcare industries.

Frequently Asked Questions

Q: What is Science Corp's PRIMA implant?
A: The PRIMA implant is a biohybrid brain-computer interface developed by Science Corp that has demonstrated success in restoring vision for individuals with severe vision loss. It works by using a pair of glasses with a camera to transmit visual data to a chip implanted in the retina.

Q: What are the potential future applications of Science Corp's technology?
A: Beyond restoring vision, Science Corp is exploring applications for its brain-implanted sensors to help heal damaged brain cells, provide early warnings for seizures, and potentially treat neurological conditions such as Parkinson's disease. The company also aims to create new ways for humans to interact with machines through brain-computer interfaces.

Q: What is Max Hodak's background in this field?
A: Max Hodak has a strong background in biomedical engineering and neural interfaces. He previously co-founded Neuralink, a company that popularized the concept of brain implants, and has been involved in brain-computer interface research since his university days.